These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 323298

  • 1. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension.
    Cocke TB, Fisch S, Gilmore HR, Okun R, Tamagna IG, Wipplinger K.
    J Clin Pharmacol; 1977; 17(5-6):334-8. PubMed ID: 323298
    [Abstract] [Full Text] [Related]

  • 2. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG, Hollifield JW, Liddle GW.
    JAMA; 1974 Feb 04; 227(5):518-21. PubMed ID: 4589187
    [No Abstract] [Full Text] [Related]

  • 3. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A, Eisalo A, Manninen V.
    Acta Med Scand; 1979 Feb 04; 205(4):319-24. PubMed ID: 373393
    [Abstract] [Full Text] [Related]

  • 4. Hydrochlorothiazide in combination with potassium-sparing agents in the treatment of hypertension.
    Dean S, Spencer-Mills L.
    Curr Med Res Opin; 1984 Feb 04; 9(5):287-9. PubMed ID: 6397330
    [Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of hydrochlorothiazide plus triameterene therapy versus chlorthalidone therapy in hypertension.
    Clark EC, Podolsky S, Thompson EJ.
    South Med J; 1979 Jul 04; 72(7):798-802. PubMed ID: 377507
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W, Baehre M, Volkers P.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul 04; 27(7):342-5. PubMed ID: 2674028
    [Abstract] [Full Text] [Related]

  • 7. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG, Qureshi SM, Richards HH, Sharma SK, Wright FG, Young PH, Rowley-Jones D.
    Br J Clin Pract; 1987 Oct 04; 41(10):947-53. PubMed ID: 3333144
    [No Abstract] [Full Text] [Related]

  • 8. [Cross-over study on therapy indicators and blood pressure lowering action of beta-receptor blocker atenolol and the diuretic combination triamterene/hydrochlorothiazide].
    Walter U, Cordes U, Philipp T, Distler A.
    Verh Dtsch Ges Inn Med; 1987 Oct 04; 83():311-4. PubMed ID: 347804
    [No Abstract] [Full Text] [Related]

  • 9. Diuretic therapies in low renin and normal renin essential hypertension.
    Brooks CS, Johnson CA, Kotchen JM, Kotchen TA.
    Clin Pharmacol Ther; 1977 Jul 04; 22(1):14-20. PubMed ID: 326459
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M, Perkal M, Tabatznik B, Cane RC, Costello K, Goodwin P.
    Clin Pharm; 1989 Jul 04; 8(7):496-500. PubMed ID: 2752698
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
    Sanguigni D, Benvenuti C.
    Clin Ter; 1978 Oct 15; 87(1):69-74. PubMed ID: 737980
    [No Abstract] [Full Text] [Related]

  • 12. Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination.
    Nash DT.
    J Med; 1977 Oct 15; 8(5):367-77. PubMed ID: 338851
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR, Dillon KR.
    J Clin Pharmacol; 1990 Aug 15; 30(8):715-9. PubMed ID: 2401750
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B.
    J Clin Pharmacol; 1977 Jul 15; 17(7):420-30. PubMed ID: 328540
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
    Schnaper HW, Maxwell MH.
    Am J Cardiol; 1989 Jan 17; 63(4):32B-36B. PubMed ID: 2643290
    [Abstract] [Full Text] [Related]

  • 16. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B, Hansson L.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 17; 20(6):291-5. PubMed ID: 7049966
    [Abstract] [Full Text] [Related]

  • 17. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G, Weinberger MH.
    Clin Pharmacol Ther; 1979 Jan 17; 25(1):33-42. PubMed ID: 363334
    [Abstract] [Full Text] [Related]

  • 18. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ.
    Hypertension; 2005 Aug 17; 46(2):313-20. PubMed ID: 15998706
    [Abstract] [Full Text] [Related]

  • 19. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J, Woo KS, Kin T, Vallance-Owen J.
    Arch Intern Med; 1987 Aug 17; 147(8):1386-9. PubMed ID: 2820329
    [Abstract] [Full Text] [Related]

  • 20. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK, Bannon JA.
    Am J Med; 1986 Apr 25; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.